Lonza announces first GMP batch completion at next-generation mammalian manufacturing facility in US
First GMP batch released at Lonza’s next-generation mammalian manufacturing facility in Portsmouth (US)
First GMP batch released at Lonza’s next-generation mammalian manufacturing facility in Portsmouth (US)
The GL 22 Blood Glucose Monitor combines German precision with advanced technology designed to meet local needs
The Scheme is subject to approval of the secured creditors and shareholders of TML and GTBL
The centre features a cutting-edge climatic chamber for stability testing and spectrophotometry to ensure that products meet the most stringent manufacturing and testing standards
New research labs and process development services to enable next generation therapeutics
Bringing a new drug to market takes about 10 years and requires an investment of approximately $1 billion
The collaboration offers opportunities for training, research fellowships, workshops and conferences at palliative care centers managed by Ajit Isaac Foundation
Genext Genomics can now offer comprehensive solutions that support the growth of India’s biotech ecosystem
The new facility significantly increases Siegfried’s R&D capacity to drive development excellence and further growth
Emcure has launched an awareness campaign to help spread the word about male anemia
Subscribe To Our Newsletter & Stay Updated